Anbio Biotechnology (NASDAQ:NNNN) Stock Price Down 8.2% – Time to Sell?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price was down 8.2% during mid-day trading on Wednesday . The stock traded as low as $12.60 and last traded at $12.5830. 7,772 shares were traded during trading, a decline of 83% from the average session volume of 44,722 shares. The stock had previously closed at $13.71.

Analyst Ratings Changes

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

Anbio Biotechnology Trading Down 5.9%

The business has a fifty day moving average of $24.34.

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.